Novel pharmaceuticals from Kenyan cyanobacteria
Dzeha, T. (2004). Novel pharmaceuticals from Kenyan cyanobacteria. WIOMSA: [s.l.]. 24 pp.
|  |
| Trefwoorden |
Chemistry
Pharmaceuticals
Bacillus licheniformis; [WoRMS]
Marien/Kust |
| Abstract |
Two projects undertaken at the Heriot-Watt University, Edinburgh, U.K as part of the WIOMSA Marg II Programme are presented here. Project 1 was on studies carried out on the Kenyan marine cyanobacterium Lyngbya majuscule, which was collected from Shimoni, 100 km south of Mombasa, Kenya and ferried to the U.K on 12th October 2003. Specifically, L. majuscule was investigated on the potential for bioprocess intensified production of secondary metabolites with therapeutic potential, the chemistry of its secondary metabolites and that of the cultures, and on the 16S rDNA classification of its epiphytic bacteria isolates. Project 2 focused on the isolation of cell-cell signaling inducer compounds from biofilms of marine bacteria Bacillus licheniformis EI-34-6. |
|
